Myomo (MYO) Net Shares Issued and Repurchased (2016 - 2024)
Myomo's (MYO) quarterly Net Shares Issued and Repurchased came in at $1283.0 in Q4 2024, down 89.41% on a YoY basis from $12113.0 in Q1 2024, and down 89.41% quarter-over-quarter from $12113.0 in Q4 2023.
Powered by 
Analysis
Myomo (MYO) Net Shares Issued and Repurchased (2016 - 2024) Analysis & Trends
Myomo (MYO) has reported Net Shares Issued and Repurchased for 9 consecutive years, with $1283.0 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Net Shares Issued and Repurchased fell 89.41% year-over-year to $1283.0; the trailing twelve-month figure through Dec 2024 stood at $1283.0 (down 89.41% YoY), and the FY2024 full-year result was $1283.0, down 89.41% from the prior year.
- Net Shares Issued and Repurchased declined to $1283.0 in Q4 2024 per MYO's latest filing, from $12113.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $48005.0 in Q4 2020 and bottomed at $616.0 in Q1 2021.
- Historically, Net Shares Issued and Repurchased has averaged $9378.1 across 5 years, with a median of $3250.0 in 2021.
- The sharpest annual moves came in 2020 and 2024: Net Shares Issued and Repurchased soared 695.71% in 2020, then tumbled 89.41% in 2024.
- Over 5 years, Net Shares Issued and Repurchased stood at $48005.0 in 2020, then sank by 80.73% to $9250.0 in 2021, then surged by 36.37% to $12614.0 in 2022, then decreased by 3.97% to $12113.0 in 2023, then sank by 89.41% to $1283.0 in 2024.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $1283.0, $12113.0, and $1700.0 for Q4 2024, Q4 2023, and Q1 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | - |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 1,283.00 |
| Dec 31, 2023 | 12,113.00 |
| Mar 31, 2023 | 1,700.00 |
| Dec 31, 2022 | 12,614.00 |
| Mar 31, 2022 | 1,700.00 |
| Dec 31, 2021 | 9,250.00 |
| Sep 30, 2021 | 1,750.00 |
| Jun 30, 2021 | 4,750.00 |
| Mar 31, 2021 | 616.00 |
| Dec 31, 2020 | 48,005.00 |
| Dec 31, 2019 | 6,033.00 |
| Sep 30, 2019 | 150.00 |
| Jun 30, 2019 | 3,416.00 |
| Mar 31, 2019 | 2,467.00 |
| Dec 31, 2018 | 12,506.00 |
| Sep 30, 2018 | 41,000.00 |
| Jun 30, 2018 | 30,500.00 |
| Mar 31, 2018 | 206,500.00 |
| Dec 31, 2017 | 210,600.00 |
| Sep 30, 2017 | 22,000.00 |